NEW YORK (GenomeWeb) – OpGen announced today that the New York State Department of Health has approved its Acuitas MDRO Gene Test for use by doctors and healthcare providers in the state.

Acuitas provides information on the presence of 10 MDRO resistance genes in a single sample from a patient. Approval of OpGen's CLIA laboratory to perform testing in New York includes approval for the complete OpGen MDRO testing workflow, including gene testing on perianal swabs and clinical isolates.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.

Sponsored by
Swift Biosciences

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.

Sponsored by

This webinar will discuss how acoustic liquid handling can reduce the time and costs for labs performing carrier screening with next-generation sequencing.